USD 29.76
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| SYM | -6.5 | 13.5 | 16.6 | 1.3 | -24.9 | -26.4 | 199.7 | 190.3 | 190.3 | 190.3 |
| S&P 500 | 1.0 | 3.7 | 2.1 | 2.3 | 8.2 | 25.4 | 31.0 | 80.6 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | SYM |
| name | Symbotic Inc. |
| price | 29.76 |
| changes percentage | -6.4739 |
| change | -2.06 |
| day low | 29.65 |
| day high | 32.3754 |
| year high | 52.2 |
| year low | 17.11 |
| market cap | 17481597862 |
| price avg 50 | 28.5048 |
| price avg 200 | 31.613625 |
| exchange | NASDAQ |
| volume | 4137272 |
| avg volume | 2572416 |
| open | 31.6 |
| previous close | 31.82 |
| eps | -0.14 |
| pe | -212.57 |
| earnings announcement | 2025-02-03T12:00:00.000+0000 |
| shares outstanding | 587419283 |
| timestamp | 2025-01-17 21:00:00 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001837240 | |||
| revenue | 1788179000 | 1176891000 | 51.94 |
| gross profit | 245666000 | 189739000 | 29.48 |
| gross profit ratio | 0.14 | 0.16 | -14.79 |
| research and development expenses | 173457000 | 195042000 | -11.07 |
| operating expenses | 362391000 | 412969000 | -12.25 |
| interest income | 0 | 0 | NaN |
| interest expense | 0 | 0 | NaN |
| ebitda | -93245000 | -203039000 | 54.08 |
| ebitdaratio | -0.05 | -0.17 | 69.77 |
| operating income | -116725000 | -223230000 | 47.71 |
| operating income ratio | -0.07 | -0.19 | 65.59 |
| net income | -13490000 | -23866000 | 43.48 |
| net income ratio | -0.01 | -0.02 | 62.80 |
| eps | -0.14 | -0.37 | 62.16 |
Revenue Growth: revenue increased to 1,788 million in 2024 from 1,177 million in 2023 representing a change of 51.94%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 246 million in 2024 from 190 million in 2023 representing a change of 29.48%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to 362 million in 2024 from 413 million in 2023 representing a change of -12.25%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -93 million in 2024 from -203 million in 2023 representing a change of 54.08%. The increase in EBITDA indicates improved operational efficiency and profitability.
Earnings per Share (EPS): EPS increased to -0.14 in 2024 from -0.14 in 2023 representing a change of 62.16%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Research and Development (R&D) Expenses: R&D Expenses decreased to 173 million in 2024 from 195 million in 2023 representing a change of -11.07%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Operating Income: Operating income decreased to -117 million in 2024 from -223 million in 2023 representing a change of 47.71%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to -13 million in 2024 from -24 million in 2023 representing a change of 43.48%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
| 2024Q4 | 2024Q3 | Q/Q change % | |
|---|---|---|---|
| 0001837240 | |||
| revenue | 503566000 | 491862000 | 2.38 |
| gross profit | 63991000 | 67406000 | -5.07 |
| gross profit ratio | 0.13 | 0.14 | -7.27 |
| research and development expenses | 40131000 | 44722000 | -10.27 |
| operating expenses | 85528000 | 92593000 | -7.63 |
| interest income | 0 | 0 | NaN |
| interest expense | 0 | 0 | NaN |
| ebitda | -15105000 | -14491000 | -4.24 |
| ebitdaratio | -0.03 | -0.03 | -1.81 |
| operating income | -21537000 | -25187000 | 14.49 |
| operating income ratio | -0.04 | -0.05 | 16.48 |
| net income | -2494000 | -2488000 | -0.24 |
| net income ratio | -0.0 | -0.01 | 2.09 |
| eps | 0.11 | -0.02 | 556.43 |
Revenue Growth: revenue increased to 504 million in 2024Q4 from 492 million in 2024Q3 representing a change of 2.38%. This indicates a sales growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to 86 million in 2024Q4 from 93 million in 2024Q3 representing a change of -7.63%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -15 million in 2024Q4 from -14 million in 2024Q3 representing a change of -4.24%. The increase in EBITDA indicates improved operational efficiency and profitability.
Net Income: Net income increased to -2 million in 2024Q4 from -2 million in 2024Q3 representing a change of -0.24%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.11 in 2024Q4 from 0.11 in 2024Q3 representing a change of 556.43%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Gross Profit: Gross Profit decreased to 64 million in 2024Q4 from 67 million in 2024Q3 representing a change of -5.07%. This indicates a sales profitability decline, which is a negative sign for the company.
Research and Development (R&D) Expenses: R&D Expenses decreased to 40 million in 2024Q4 from 45 million in 2024Q3 representing a change of -10.27%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Operating Income: Operating income decreased to -22 million in 2024Q4 from -25 million in 2024Q3 representing a change of 14.49%. The decrease in operating income indicates worse operational performance and decreased profitability.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001837240 | |||
| total assets | 1578552000 | 1050710000 | 50.24 |
| total liabilities | 1188422000 | 1053426000 | 12.81 |
| total equity | 390130000 | -2716000 | 14464.14 |
| cash and cash equivalents | 727310000 | 258770000 | 181.06 |
| short term investments | 0 | 286736000 | -100.00 |
| long term investments | 81289000 | 0 | NaN |
| total current assets | 1355537000 | 991795000 | 36.68 |
| total non current assets | 223015000 | 58915000 | 278.54 |
| total current liabilities | 1017146000 | 1025459000 | -0.81 |
| total non current liabilities | 171276000 | 27967000 | 512.42 |
| common stock | 13000 | 56000 | -76.79 |
| retained earnings | -1323925000 | -1310435000 | -1.03 |
| total debt | 0 | 13638000 | -100.00 |
Total Assets: Total Assets increased to 1,579 million in 2024 from 1,051 million in 2023 representing a change of 50.24%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 390 million in 2024 from -3 million in 2023 representing a change of 14464.14%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 727 million in 2024 from 259 million in 2023 representing a change of 181.06%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 1,356 million in 2024 from 992 million in 2023 representing a change of 36.68%. This indicates a better liquidity position.
Total Current Liabilities: Total Current Liabilities decreased to 1,017 million in 2024 from 1,025 million in 2023 representing a change of -0.81%. This indicates a lower short-term debt burden.
Total Debt: Total Debt decreased to 0 million in 2024 from 14 million in 2023 representing a change of -100.0%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 1,188 million in 2024 from 1,053 million in 2023 representing a change of 12.81%. This indicates an increase in overall liabilities.
Short Term Investments: Short Term Investments decreased to 0 million in 2024 from 287 million in 2023 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.
Common Stock: Common Stock decreased to 0 in 2024 from 0 in 2023 representing a change of -76.79%. This indicates a decrease in ownership interest.
Retained Earnings: Retained Earnings decreased to -1,324 million in 2024 from -1,310 million in 2023 representing a change of -1.03%. This indicates an accumulated losses.
| 2024Q4 | 2024Q3 | Q/Q change % | |
|---|---|---|---|
| 0001837240 | |||
| total assets | 1578552000 | 1558442000 | 1.29 |
| total liabilities | 1188422000 | 1179147000 | 0.79 |
| total equity | 396044000 | 379295000 | 4.42 |
| cash and cash equivalents | 727310000 | 870469000 | -16.45 |
| short term investments | 0 | 0 | NaN |
| long term investments | 81289000 | 0 | NaN |
| total current assets | 1355537000 | 1371317000 | -1.15 |
| total non current assets | 223015000 | 187125000 | 19.18 |
| total current liabilities | 1017146000 | 1048093000 | -2.95 |
| total non current liabilities | 171276000 | 131054000 | 30.69 |
| common stock | 13000 | 61000 | -78.69 |
| retained earnings | -1323925000 | -1321431000 | -0.19 |
| total debt | 0 | 18175000 | -100.00 |
Total Assets: Total Assets increased to 1,579 million in 2024Q4 from 1,558 million in 2024Q3 representing a change of 1.29%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 396 million in 2024Q4 from 379 million in 2024Q3 representing a change of 4.42%. This indicates an increase in shareholders' equity.
Total Current Liabilities: Total Current Liabilities decreased to 1,017 million in 2024Q4 from 1,048 million in 2024Q3 representing a change of -2.95%. This indicates a lower short-term debt burden.
Total Debt: Total Debt decreased to 0 million in 2024Q4 from 18 million in 2024Q3 representing a change of -100.0%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 1,188 million in 2024Q4 from 1,179 million in 2024Q3 representing a change of 0.79%. This indicates an increase in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 727 million in 2024Q4 from 870 million in 2024Q3 representing a change of -16.45%. This indicates a decrease in available liquid assets.
Total Current Assets: Total Current Assets decreased to 1,356 million in 2024Q4 from 1,371 million in 2024Q3 representing a change of -1.15%. This indicates a worsen liquidity position.
Common Stock: Common Stock decreased to 0 in 2024Q4 from 0 in 2024Q3 representing a change of -78.69%. This indicates a decrease in ownership interest.
Retained Earnings: Retained Earnings decreased to -1,324 million in 2024Q4 from -1,321 million in 2024Q3 representing a change of -0.19%. This indicates an accumulated losses.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0001837240 | |||
| net change in cash | 469436000 | -92539000 | 607.28 |
| operating cash flow | -58077000 | 230794000 | -125.16 |
| free cash flow | -102451000 | 209468000 | -148.91 |
| capital expenditure | -44374000 | -21326000 | -108.07 |
| depreciation and amortization | 23480000 | 11311000 | 107.59 |
| deferred income tax | 3917000 | -4620000 | 184.78 |
| stock based compensation | 112208000 | 154227000 | -27.24 |
| accounts payables | 65270000 | 41415000 | 57.60 |
| inventory | 103000 | -44104000 | 100.23 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -44374000 | -15688000 | -182.85 |
| net cash used for investing activites | 156481000 | -299464000 | 152.25 |
| debt repayment | 0 | 0 | NaN |
| common stock issued | 257985000 | 2573000 | 9926.62 |
| common stock repurchased | 0 | -26674000 | 100.00 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 371036000 | -24101000 | 1639.50 |
| cash at end of period | 730354000 | 260918000 | 179.92 |
| accounts receivables | -132305000 | -65817000 | -101.02 |
| cash at beginning of period | 260918000 | 353457000 | -26.18 |
Net Change in Cash: Net Change in Cash increased to 469 million in 2024 from -93 million in 2023 representing a change of 607.28%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Capital Expenditure: Capital Expenditure decreased to -44 million in 2024 from -21 million in 2023 representing a change of -108.07%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 112 million in 2024 from 154 million in 2023 representing a change of -27.24%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Receivables: Accounts Receivables decreased to -132 million in 2024 from -66 million in 2023 representing a change of -101.02%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Operating Cash Flow: Operating Cash Flow decreased to -58 million in 2024 from 231 million in 2023 representing a change of -125.16%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to -102 million in 2024 from 209 million in 2023 representing a change of -148.91%. This indicates a decrease in cash generated after accounting for capital expenditures.
Deferred Income Tax: Deferred Income Tax increased to 4 million in 2024 from -5 million in 2023 representing a change of 184.78%. This indicates that the company's tax liability for future periods has increased.
Accounts Payables: The absolute value of Accounts Payables increased to 65 million in 2024 from 41 million in 2023 representing a change of 57.6%. This indicates that the company has increased its outstanding obligations to its suppliers.
| 2024Q4 | 2024Q3 | Q/Q change % | |
|---|---|---|---|
| 0001837240 | |||
| operating cash flow | -99383000 | 50384000 | -297.25 |
| free cash flow | -120747000 | 33241000 | -463.25 |
| capital expenditure | -21367000 | -17143000 | -24.64 |
| depreciation and amortization | 6432000 | 10696000 | -39.87 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 25350000 | 29331000 | -13.57 |
| accounts receivables | -101010000 | 27166000 | -471.83 |
| accounts payables | 47483000 | 6458000 | 635.26 |
| inventory | 30202000 | 0 | NaN |
| acquisitions net | -820000 | 0 | NaN |
| investments in property plant and equipment | -21367000 | -16846000 | -26.84 |
| net cash used for investing activites | -45363000 | -33632000 | -34.88 |
| debt repayment | 0 | 0 | NaN |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | 2309000 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 1747000 | -47652000 | 103.67 |
| net change in cash | -142978000 | -30910000 | -362.56 |
| cash at end of period | 730354000 | 873332000 | -16.37 |
| cash at beginning of period | 873332000 | 904242000 | -3.42 |
Net Change in Cash: Net Change in Cash decreased to -143 million in 2024Q4 from -31 million in 2024Q3 representing a change of -362.56%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow decreased to -99 million in 2024Q4 from 50 million in 2024Q3 representing a change of -297.25%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to -121 million in 2024Q4 from 33 million in 2024Q3 representing a change of -463.25%. This indicates a decrease in cash generated after accounting for capital expenditures.
Accounts Payables: The absolute value of Accounts Payables increased to 47 million in 2024Q4 from 6 million in 2024Q3 representing a change of 635.26%. This indicates that the company has increased its outstanding obligations to its suppliers.
Capital Expenditure: Capital Expenditure decreased to -21 million in 2024Q4 from -17 million in 2024Q3 representing a change of -24.64%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 25 million in 2024Q4 from 29 million in 2024Q3 representing a change of -13.57%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Receivables: Accounts Receivables decreased to -101 million in 2024Q4 from 27 million in 2024Q3 representing a change of -471.83%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q4 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2024-09-28 | 2023-09-30 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2024 | 2023 | NaN |
| revenue per share | 18.69 | 18.29 | 2.15 |
| net income per share | -0.14 | -0.37 | 62.00 |
| operating cash flow per share | -0.61 | 3.59 | -116.92 |
| free cash flow per share | -1.07 | 3.26 | -132.88 |
| cash per share | 7.6 | 8.48 | -10.36 |
| book value per share | 4.08 | -0.04 | 9757.22 |
| tangible book value per share | 4.04 | -0.05 | 8958.73 |
| shareholders equity per share | 4.08 | 0.0 | 319765.91 |
| interest debt per share | 0 | 0.21 | -100.00 |
| market cap | 2442196831.36 | 2150843576.75 | 13.55 |
| enterprise value | 1714886831.36 | 1905711576.75 | -10.01 |
| pe ratio | -181.04 | -90.12 | -100.88 |
| price to sales ratio | 1.37 | 1.83 | -25.27 |
| pocfratio | -42.05 | 9.32 | -551.22 |
| pfcf ratio | -23.84 | 10.27 | -332.15 |
| pb ratio | 6.26 | 26229.8 | -99.98 |
| ptb ratio | 6.26 | 26229.8 | -99.98 |
| ev to sales | 0.96 | 1.62 | -40.78 |
| enterprise value over ebitda | -18.39 | -9.39 | -95.94 |
| ev to operating cash flow | -29.53 | 8.26 | -457.60 |
| ev to free cash flow | -16.74 | 9.1 | -283.98 |
| earnings yield | -0.01 | -0.01 | 50.22 |
| free cash flow yield | -0.04 | 0.1 | -143.08 |
| debt to equity | 0 | 166.32 | -100.00 |
| debt to assets | 0 | 0.01 | -100.00 |
| net debt to ebitda | 7.8 | 1.21 | 546.06 |
| current ratio | 1.33 | 0.97 | 37.79 |
| interest coverage | 0 | 0 | NaN |
| income quality | 0.69 | -1.11 | 161.78 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0.1 | 0.17 | -41.47 |
| intangibles to total assets | 0.0 | 0.0 | 1023.88 |
| capex to operating cash flow | -0.76 | 0.09 | -926.87 |
| capex to revenue | 0.02 | 0.02 | 36.94 |
| capex to depreciation | 1.89 | 1.89 | 0.24 |
| stock based compensation to revenue | 0.06 | 0.13 | -52.12 |
| graham number | 3.6 | 0.1 | 3386.47 |
| roic | -0.22 | -8.65 | 97.47 |
| return on tangible assets | -0.01 | -0.02 | 62.30 |
| graham net net | -0.97 | -4.62 | 78.91 |
| working capital | 338391000 | -33664000 | 1105.20 |
| tangible asset value | 386466000 | -2933000 | 13276.47 |
| net current asset value | 167115000 | -61631000 | 371.15 |
| invested capital | 439164000 | 1060000 | 41330.57 |
| average receivables | 305068000 | 147791500 | 106.42 |
| average payables | 142553000 | 89183000 | 59.84 |
| average inventory | 121128500 | 114010500 | 6.24 |
| days sales outstanding | 85.68 | 59.04 | 45.14 |
| days payables outstanding | 41.45 | 40.64 | 2.00 |
| days of inventory on hand | 25.11 | 50.33 | -50.10 |
| receivables turnover | 4.26 | 6.18 | -31.10 |
| payables turnover | 8.8 | 8.98 | -1.96 |
| inventory turnover | 14.53 | 7.25 | 100.40 |
| roe | -0.03 | -291.05 | 99.99 |
| capex per share | 0.46 | 0.33 | 39.89 |
ROE: Return on Equity (ROE) increased to -0.03 on 2024-09-28 from -291.05 on 2023-09-30, representing a change of 99.99%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -181.04 on 2024-09-28 from -90.12 on 2023-09-30, representing a change of -100.88%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.33 on 2024-09-28 from 0.97 on 2023-09-30, representing a change of 37.79%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-09-28 from 166.32 on 2023-09-30, representing a change of -100.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-28 Q4 | 2024-06-29 Q3 | Q/Q change % | |
|---|---|---|---|
| SYM | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 5.26 | 4.77 | 10.29 |
| net income per share | -0.03 | -0.02 | -7.99 |
| operating cash flow per share | -1.04 | 0.49 | -312.50 |
| free cash flow per share | -1.26 | 0.32 | -491.33 |
| cash per share | 7.6 | 8.44 | -9.99 |
| book value per share | 4.08 | 3.68 | 10.81 |
| tangible book value per share | 4.04 | 3.68 | 9.77 |
| shareholders equity per share | 2.12 | 4.06 | -47.73 |
| interest debt per share | 0 | 0.18 | -100.00 |
| market cap | 2442196831.36 | 3624859544.04 | -32.63 |
| enterprise value | 1714886831.36 | 2772565544.04 | -38.15 |
| pe ratio | -244.81 | -364.23 | 32.79 |
| price to sales ratio | 4.85 | 7.37 | -34.19 |
| pocfratio | -24.57 | 71.94 | -134.16 |
| pfcf ratio | -20.23 | 109.05 | -118.55 |
| pb ratio | 12.02 | 8.66 | 38.86 |
| ptb ratio | 12.02 | 8.66 | 38.86 |
| ev to sales | 3.41 | 5.64 | -39.59 |
| enterprise value over ebitda | -113.53 | -191.33 | 40.66 |
| ev to operating cash flow | -17.26 | 55.03 | -131.36 |
| ev to free cash flow | -14.2 | 83.41 | -117.03 |
| earnings yield | -0.0 | -0.0 | -48.78 |
| free cash flow yield | -0.05 | 0.01 | -639.15 |
| debt to equity | 0 | 0.04 | -100.00 |
| debt to assets | 0 | 0.01 | -100.00 |
| net debt to ebitda | 48.15 | 58.82 | -18.13 |
| current ratio | 1.33 | 1.31 | 1.86 |
| interest coverage | 0 | 0 | NaN |
| income quality | 6.01 | -20.25 | 129.66 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0.08 | 0.09 | -12.35 |
| intangibles to total assets | 0.0 | 0 | NaN |
| capex to operating cash flow | -0.21 | 0.34 | -163.19 |
| capex to revenue | 0.04 | 0.03 | 21.74 |
| capex to depreciation | 3.32 | 1.6 | 107.27 |
| stock based compensation to revenue | 0.05 | 0.06 | -15.58 |
| graham number | 1.12 | 1.48 | -24.87 |
| roic | -0.05 | -0.05 | -4.24 |
| return on tangible assets | -0.0 | -0.0 | 0.81 |
| graham net net | -0.97 | -0.45 | -114.87 |
| working capital | 338391000 | 323224000 | 4.69 |
| tangible asset value | 386466000 | 379295000 | 1.89 |
| net current asset value | 167115000 | 192170000 | -13.04 |
| invested capital | 439164000 | 420177000 | 4.52 |
| average receivables | 340484000 | 281429500 | 20.98 |
| average payables | 165737000 | 153057500 | 8.28 |
| average inventory | 119123499.5 | 125941499.5 | -5.41 |
| days sales outstanding | 75.03 | 47.79 | 56.98 |
| days payables outstanding | 35.87 | 33.14 | 8.24 |
| days of inventory on hand | 21.73 | 28.01 | -22.42 |
| receivables turnover | 1.2 | 1.88 | -36.30 |
| payables turnover | 2.51 | 2.72 | -7.61 |
| inventory turnover | 4.14 | 3.21 | 28.91 |
| roe | -0.01 | -0.01 | -106.60 |
| capex per share | 0.22 | 0.17 | 34.28 |
ROE: Return on Equity (ROE) decreased to -0.01 on 2024-09-28 Q4 from -0.01 on 2024-06-29 Q3, representing a change of -106.60%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -244.81 on 2024-09-28 Q4 from -364.23 on 2024-06-29 Q3, representing a change of 32.79%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 1.33 on 2024-09-28 Q4 from 1.31 on 2024-06-29 Q3, representing a change of 1.86%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-09-28 Q4 from 0.04 on 2024-06-29 Q3, representing a change of -100.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Neutral
Publish Date: 2025-01-17 22:50:00
NEW ORLEANS , Jan. 17, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 3, 2025 to file lead plaintiff applications in a securities class action lawsuit against Symbotic Inc. (the "Company") (NasdaqGM: SYM), if they purchased the Company's securities between February 8, 2024 and November 26, 2024, inclusive (the "Class Period").
Sentiment: Negative
Publish Date: 2025-01-17 15:45:00
NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123529&wire=1 or contact Joseph E. Levi, Esq.
Sentiment: Negative
Publish Date: 2025-01-17 15:18:00
NEW YORK, NY / ACCESS Newswire / January 17, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Symbotic Inc. (NASDAQ:SYM) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Symbotic, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/symbotic-inc.
Sentiment: Negative
Publish Date: 2025-01-17 15:00:00
NEW YORK, NY / ACCESSWIRE / January 17, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123519&wire=1 or contact Joseph E. Levi, Esq.
Sentiment: Positive
Publish Date: 2025-01-17 14:48:00
NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Symbotic Inc. (NASDAQ: SYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.
Sentiment: Negative
Publish Date: 2025-01-17 14:30:00
NEW YORK CITY, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123510&wire=1 or contact Joseph E. Levi, Esq.
Sentiment: Negative
Publish Date: 2025-01-17 14:00:00
NEW YORK CITY, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123504&wire=1 or contact Joseph E. Levi, Esq.
Sentiment: Negative
Publish Date: 2025-01-17 13:41:00
SAN FRANCISCO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (NASDAQ: SYM), a Wilmington, Mass.-based automation technology company, has filed restated financial statements for three fiscal 2024 quarters, revealing significant errors in its previously reported revenue and profitability figures. The restatements, filed on December 4, follow the revelation of accounting errors last month and come as the company faces a securities fraud class action lawsuit.
Sentiment: Negative
Publish Date: 2025-01-17 12:15:00
NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123467&wire=1 or contact Joseph E. Levi, Esq.
Sentiment: Negative
Publish Date: 2025-01-17 11:15:00
NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123425&wire=1 or contact Joseph E. Levi, Esq.
Sentiment: Positive
Publish Date: 2025-01-17 10:26:13
Symbotic is set to buy WMT's Advanced Systems and Robotics business, a move to enhance Walmart's Accelerated Pickup and Delivery capabilities at its stores.
Sentiment: Negative
Publish Date: 2025-01-17 10:15:00
LOS ANGELES, CA / ACCESS Newswire / January 17, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Symbotic Inc. ("Symbotic" or "the Company") (NASDAQ:SYM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 8, 2024 and November 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 3, 2025.
Sentiment: Positive
Publish Date: 2025-01-17 10:02:37
SYMBOTIC INC (SYM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Sentiment: Negative
Publish Date: 2025-01-17 09:52:00
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Symbotic To Contact Him Directly To Discuss Their Options
Sentiment: Positive
Publish Date: 2025-01-17 09:25:28
SYMBOTIC INC (SYM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Sentiment: Negative
Publish Date: 2025-01-17 09:15:00
NEW YORK, NY / ACCESS Newswire / January 17, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123407&wire=1 or contact Joseph E. Levi, Esq.
Sentiment: Positive
Publish Date: 2025-01-17 08:39:00
NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Symbotic Inc. (NASDAQ: SYM) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Symbotic, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/symbotic-inc.
Sentiment: Negative
Publish Date: 2025-01-17 07:00:00
NEW YORK, NY / ACCESS Newswire / January 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Symbotic Inc. ("Symbotic" or "the Company") (NASDAQ:SYM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Symbotic securities between February 8, 2024 and November 26, 2024, both dates inclusive (the "Class Period").
Sentiment: Negative
Publish Date: 2025-01-17 05:45:00
NEW YORK , Jan. 17, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Symbotic Inc. ("Symbotic" or the "Company") (NASDAQ: SYM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Symbotic investors who were adversely affected by alleged securities fraud between February 8, 2024 and November 26, 2024.
Sentiment: Negative
Publish Date: 2025-01-16 20:45:00
NEW YORK, NY / ACCESS Newswire / January 16, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123333&wire=1 or contact Joseph E. Levi, Esq.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
